Toggle light / dark theme

While we are used to the idea of teeth only growing twice, a new drug could make it possible to grow a third set.

Scientists are making significant strides in the development of a groundbreaking drug that could potentially enable the regrowth of teeth.

Clinical trials are scheduled to commence in July next year. They hope it will be available for dentists to use by 2030.

A recent paper published in Nature Aging by researchers from Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning.

Machine learning is a subset of artificial intelligence (AI) that deals with the development of algorithms and statistical models that enable computers to learn from data and make predictions or decisions without being explicitly programmed to do so. Machine learning is used to identify patterns in data, classify data into different categories, or make predictions about future events. It can be categorized into three main types of learning: supervised, unsupervised and reinforcement learning.

Ark Invest, which is led by CEO Cathie Wood, has been pouring money into semiconductor stocks lately and has made another notable purchase. According to portfolio updates published by the firm yesterday, Wood’s company has increased its investment in Quantum-Si (QSI-6.20%) — a small-cap biotech with a specialized, chip-based platform for protein sequencing.

Ark Invest regularly publishes information about stocks that have been bought and sold for its exchange-traded funds (ETFs), and a recent update showed it purchased more than 1.4 million shares of Quantum-Si stock for its Ark Genomic Revolution ETF (ARKG-1.84%) on Thursday. The purchase would have been valued at roughly $3.7 million based on the stock’s price at market close yesterday, and is the largest investment that Ark has made in the healthcare-tech upstart’s stock so far.

So the question is: Why is Wood excited about this little-known life sciences player?

Scientists have achieved a major breakthrough in combating ageing and age-related diseases. The study by the researchers from Harvard Medical School and Massachusetts Institute of Technology was published in the journal Aging-US.

Humanity’s attempt to prevent ageing: What is the breakthrough?

The researchers have introduced a chemical method through a ‘single pill’ to reprogram body cells, following which the cells effectively return to a younger state.

Imagine a wearable patch that tracks your vital signs through changes in the color display, or shipping labels that light up to indicate changes in temperature or sterility of food items.

These are among the potential uses for a new flexible display created by UBC researchers and announced recently in ACS Applied Materials & Interfaces.

“This device is capable of fast, realtime and reversible color change,” says researcher Claire Preston, who developed the device as part of her master’s in electrical and computer engineering at UBC. “It can stretch up to 30 percent without losing performance. It uses a color-changing technology that can be used for visual monitoring. And it is relatively cheap to manufacture.”